Cardiometabolic evaluation of small for gestational age children: protective effect of breast milk

Ana Cecília Travassos Santiago1, Louise Perna Martins da Cunha1, Mariana de Lima Costa1

  • 1Faculdade de Medicina. Universidade Federal da Bahia.

Nutricion Hospitalaria
|December 15, 2020
PubMed

Insights

Exclusive breastfeeding (EBF) may protect children born small for gestational age (SGA) from cardiometabolic risks until pre-school age. Despite initial faster weight gain, SGA children remained smaller but showed no adverse metabolic profiles.

Area of Science:

  • Pediatrics
  • Human Growth and Development
  • Metabolic Health

Background:

  • Human growth is multifactorial, involving genetic, hormonal, nutritional, and environmental influences.
  • The precise determinants of individual weight and height remain incompletely understood.
  • Children born small for gestational age (SGA) are at increased risk for chronic non-communicable diseases.

Purpose of the Study:

  • To evaluate the cardiometabolic profile of exclusively breastfed children born small for gestational age (SGA).
  • To compare cardiometabolic outcomes in SGA children versus those appropriate for gestational age (AGA).

Main Methods:

  • Prospective cohort study following term-born SGA and AGA children to pre-school age.
  • Collected anthropometric measures, body composition, and breastfeeding duration (in days).
  • Assessed cardiometabolic profile (fasting glucose, insulin, HOMA-IR, blood pressure) at 1 month and pre-school age.

Main Results:

  • Mean exclusive breastfeeding (EBF) duration was 180 days in both SGA and AGA groups.
  • 85% of SGA children achieved anthropometric catch-up within six months, with significantly faster weight gain than AGAs (p < 0.001).
  • SGA children remained smaller and thinner than AGAs at pre-school age, with no significant differences in cardiometabolic markers or obesity.

Conclusions:

  • Exclusive breastfeeding (EBF) may offer protection against cardiometabolic risks for SGA children up to pre-school age.
  • SGA children, despite catch-up growth, do not exhibit adverse cardiometabolic profiles by pre-school age in this cohort.
  • Findings suggest EBF is a potentially protective factor for SGA infants regarding long-term metabolic health.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
90
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
109
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K